# Grosvenor Holdings, L.L.C.

> Institutional holdings reported to the SEC as of Q1 2022 on Form 13F. CIK 1743987. Source: https://holderbook.com/funds/1743987-grosvenor-holdings-l-l-c/

- Reported value: $512.3M
- Positions: 14
- Weight of the ten largest: 95.2%
- Filed: 2022-05-16

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| VERRA MOBILITY CORP | [VRRM](https://holderbook.com/stocks/VRRM/) | $97.2M | 5,967,474 | 19.0% | 11 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $91.3M | 27,992 | 17.8% | 9 |
| RIVIAN AUTOMOTIVE INC | [RIVN](https://holderbook.com/stocks/RIVN/) | $78.0M | 1,553,544 | 15.2% | 2 |
| FIRST CTZNS BANCSHARES INC D | [FCNCA](https://holderbook.com/stocks/FCNCA/) | $41.1M | 61,703 | 8.0% | 1 |
| FATE THERAPEUTICS INC | [FATE](https://holderbook.com/stocks/FATE/) | $40.2M | 1,037,256 | 7.8% | 11 |
| SIGNIFY HEALTH INC | [SGFY](https://holderbook.com/stocks/SGFY/) | $35.1M | 1,932,195 | 6.8% | 3 |
| T-MOBILE US INC | [TMUS](https://holderbook.com/stocks/TMUS/) | $33.7M | 262,826 | 6.6% | 7 |
| CARVANA CO | [CVNA](https://holderbook.com/stocks/CVNA/) | $30.5M | 255,289 | 5.9% | 6 |
| ADC THERAPEUTICS SA | [ADCT](https://holderbook.com/stocks/ADCT/) | $22.3M | 1,517,212 | 4.4% | 8 |
| ATI PHYSICAL THERAPY INC | [ATIP](https://holderbook.com/stocks/ATIP/) | $18.4M | 9,807,085 | 3.6% | 3 |
| F45 TRAINING HLDGS INC | [FXLV](https://holderbook.com/stocks/FXLV/) | $13.9M | 1,302,374 | 2.7% | 3 |
| SONDER HOLDINGS INC | [SOND](https://holderbook.com/stocks/SOND/) | $9.7M | 2,045,991 | 1.9% | 1 |
| VICTORY CAP HLDGS INC DEL | [VCTR](https://holderbook.com/stocks/VCTR/) | $583.0K | 20,202 | 0.1% | 1 |
| PACIFIC BIOSCIENCES CALIF IN | [PACB](https://holderbook.com/stocks/PACB/) | $355.0K | 39,037 | 0.1% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q1 2022 | -23.4% | -4.9% | -18.5% | 88% |
| Q4 2021 | +2.3% | +10.7% | -8.4% | 98% |
| Q3 2021 | -8.3% | +0.3% | -8.6% | 100% |
| Q2 2021 | +6.0% | +8.0% | -2.0% | 100% |
| Q1 2021 | +1.0% | +6.0% | -5.0% | 100% |
| Q4 2020 | +30.5% | +11.6% | +18.9% | 100% |
| Q3 2020 | +10.0% | +8.6% | +1.4% | 100% |
| Q2 2020 | +25.6% | +19.6% | +5.9% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q1 2022 | $512.3M | 14 |
| Q4 2021 | $967.2M | 20 |
| Q3 2021 | $816.0M | 19 |
| Q2 2021 | $1.0B | 21 |
| Q1 2021 | $1.4B | 24 |
| Q4 2020 | $1.8B | 31 |
| Q3 2020 | $1.4B | 31 |
| Q2 2020 | $1.1B | 22 |
| Q1 2020 | $879.7M | 22 |
| Q4 2019 | $600.0M | 15 |
| Q3 2019 | $553.5M | 19 |
| Q2 2019 | $426.5M | 16 |